SPY331.70+1.64 0.50%
DIA271.26+2.85 1.06%
IXIC10,975.06+33.89 0.31%

Barclays Downgrades Diplomat Pharmacy to Equal-Weight, Lowers Price Target to $3

Barclays downgrades Diplomat Pharmacy (NYSE:DPLO) from Overweight to Equal-Weight and lowers the price target from $7 to $3.

Benzinga · -

Barclays downgrades Diplomat Pharmacy (NYSE:DPLO) from Overweight to Equal-Weight and lowers the price target from $7 to $3.